Cabergoline

CABERNOVA Tablets by NovaTech Sciences contain high-purity Cabergoline (CAS 81409-90-7), a dopamine receptor agonist widely used in endocrine therapy for prolactin regulation and hormone balance. Cabergoline is globally identified by CAS 81409-90-7, ensuring chemical authenticity, traceability, and pharmaceutical standardization within regulated healthcare markets.

NovaTech Sciences manufactures Cabergoline CAS 81409-90-7 under strict pharmaceutical quality control protocols designed to maintain compound purity, formulation consistency, and international export compliance.

Cabergoline is a long-acting dopamine agonist primarily used to reduce elevated prolactin levels. Registered under CAS 81409-90-7, Cabergoline acts on dopamine D2 receptors in the pituitary gland to inhibit prolactin secretion.

The CAS registry number 81409-90-7 serves as the internationally recognized chemical identifier for Cabergoline. This identifier ensures compound verification and supports regulatory transparency across pharmaceutical manufacturing and supply chains.

Cabergoline (CAS 81409-90-7) works by activating dopamine receptors located in the pituitary gland. Dopamine naturally inhibits the release of prolactin, a hormone responsible for milk production and several endocrine functions.

By stimulating these dopamine receptors, Cabergoline CAS 81409-90-7 suppresses prolactin secretion and helps restore hormonal balance. This mechanism supports several endocrine functions and contributes to improved hormonal regulation in specific clinical conditions.

Each batch of Cabergoline CAS 81409-90-7 undergoes rigorous analytical testing to confirm chemical identity, purity verification, and dosage accuracy.

NovaTech Sciences operates as a trusted manufacturer, supplier, and exporter of pharmaceutical-grade endocrine medications for global markets. By clearly specifying CAS 81409-90-7, CABERNOVA tablets maintain chemical authenticity and regulatory transparency.

These procedures ensure Cabergoline tablets meet the strict standards expected by international pharmaceutical distributors.

NovaTech Sciences prioritizes pharmaceutical precision, regulatory compliance, and product reliability. CABERNOVA tablets containing Cabergoline CAS 81409-90-7 are produced using advanced pharmaceutical manufacturing technologies designed to ensure consistent therapeutic performance.

For pharmaceutical distributors and healthcare suppliers seeking a dependable source of Cabergoline (CAS 81409-90-7), CABERNOVA Tablets by NovaTech Sciences provide verified compound identity, pharmaceutical manufacturing excellence, and reliable global supply. Supported by strict quality assurance systems, Cabergoline CAS 81409-90-7 remains a recognized dopamine agonist associated with prolactin regulation and endocrine hormone balance.